Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Chemistry

• Publication date

  2009-09-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/chem.200901090PMID 19655350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [1H,15N] NMR studies of the aquation of cis-diamine platinum(II) complexes

  2009cited by this paper
• Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.

  2009cited by this paper
• Phenotypic engineering by reprogramming gene transcription using novel artificial transcription factors in Escherichia coli

  2008cited by this paper
• Peculiar mechanistic and structural features of the carboplatin–cytochrome c system revealed by ESI-MS analysis

  2008cited by this paper
• Effects of geometric isomerism and anions on the kinetics and mechanism of the stepwise formation of long-range DNA interstrand cross-links by dinuclear platinum antitumor complexes.

  2008cited by this paper
• Trans-platinum complexes in cancer therapy.

  2007cited by this paper
• Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands.

  2007cited by this paper
• BioMagResBank

  2007cited by this paper
• Ruthenium anticancer drugs and proteins: a study of the interactions of the ruthenium(III) complex imidazolium trans-[tetrachloro(dimethyl sulfoxide)(imidazole)ruthenate(III)] with hen egg white lysozyme and horse heart cytochrome c

  2007cited by this paper
• Insights into the molecular mechanisms of protein platination from a case study: the reaction of anticancer platinum(II) iminoethers with horse heart cytochrome c.

  2007cited by this paper
• Pre-association of polynuclear platinum anticancer agents on a protein, human serum albumin. Implications for drug design.

  2007cited by this paper
• Role of carbonate in the cytotoxicity of carboplatin.

  2007cited by this paper
• Understanding the effect of carbonate ion on cisplatin binding to DNA.

  2007cited by this paper
• Exploring Metallodrug–Protein Interactions by ESI Mass Spectrometry: The Reaction of Anticancer Platinum Drugs with Horse Heart Cytochrome c

  2006cited by this paper
• Insights into the mechanism of action of platinum anticancer drugs from multinuclear NMR spectroscopy

  2006cited by this paper
• Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands.

  2006cited by this paper
• Effects of geometric isomerism in dinuclear platinum antitumor complexes on aquation reactions in the presence of perchlorate, acetate and phosphate

  2005cited by this paper
• Contrasting chemistry of cis- and trans-platinum(II) diamine anticancer compounds: hydrolysis studies of picoline complexes.

  2005cited by this paper
• Competitive reactions of a ruthenium arene anticancer complex with histidine, cytochrome c and an oligonucleotide

  2005cited by this paper
• Antitumor active trans-platinum compounds.

  2004cited by this paper
• Metal Ions in Biological Systems : Volume 42: Metal Complexes in Tumor Diagnosis and as Anticancer Agents

  2004cited by this paper
• Antitumor and cellular pharmacological properties of a novel platinum(IV) complex: trans-[PtCl(2)(OH)(2)(dimethylamine) (isopropylamine)].

  2003cited by this paper
• Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles.

  2002cited by this paper
• Kinetic study of the reaction between an antitumor 15N labeled trans-platinum iminoether complex and GMP by [1H, 15N] HMQC NMR

  2002cited by this paper
• Equilibrium and kinetic studies of the aquation of the dinuclear platinum complex [[trans-PtCl(NH3)2]2(mu-NH2(CH2)6NH2)]2+: pKa determinations of aqua ligands via [1H,15N] NMR spectroscopy.

  2000cited by this paper
• X-Ray structure of cytotoxic trans-[PtCl(2)(dimethylamine)(isopropylamine)]: interstrand cross-link efficiency, DNA sequence specificity, and inhibition of the B-Z transition.

  2000cited by this paper
• Synthesis, Structure, Biological Activity, and DNA Binding of Platinum(II) Complexes of the Type trans-[PtCl(2)(NH(3))L] (L = Planar Nitrogen Base). Effect of L and Cis/Trans Isomerism on Sequence Specificity and Unwinding Properties Observed in Globally Platinated DNA.

  1999cited by this paper
• Why does Cisplatin reach Guanine-n7 with competing s-donor ligands available in the cell?

  1999cited by this paper
• Reactions of cisplatin hydrolytes with methionine, cysteine, and plasma ultrafiltrate studied by a combination of HPLC and NMR techniques.

  1999cited by this paper
• Identification of platination sites on human serum transferrin using 13C and 15N NMR spectroscopy

  1999cited by this paper
• Preparation and characterization of novel trans-[PtCl(2)(amine)(isopropylamine)] compounds: cytotoxic activity and apoptosis induction in ras-transformed cells.

  1999cited by this paper
• PKA VALUES OF AQUA LIGANDS OF PLATINUM(II) ANTICANCER COMPLEXES : 1H, 15N AND 195PT NMR STUDIES OF CIS- AND TRANS- PTCL2(NH3)(CYCLOHEXYLAMINE)

  1998cited by this paper
• Selective Platination of Biologically Relevant Polyamines. Linear Coordinating Spermidine and Spermine as Amplifying Linkers in Dinuclear Platinum Complexes

  1997cited by this paper
• Solution structure of oxidized horse heart cytochrome c.

  1997cited by this paper
• Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.

  1996cited by this paper
• A trans-platinum complex showing higher antitumor activity than the cis congeners.

  1993cited by this paper
• Nonclassical platinum antitumor agents: perspectives for design and development of new drugs complementary to cisplatin.

  1993cited by this paper
• Activation of the trans geometry in platinum antitumor complexes. Synthesis, characterization, and biological activity of complexes with the planar ligands pyridine, N-methylimidazole, thiazole and quinoline. Crystal and molecular structure of trans-dichlorobis (thiazole)platinum(II)

  1992cited by this paper
• Cytostatic trans-platinum(II) complexes.

  1989cited by this paper
• Chemical and biological properties of a new series of cis-diammineplatinum(II) antitumor agents containing three nitrogen donors: cis-[Pt(NH3)2(N-donor)Cl]+.

  1989cited by this paper
• Role of ligand exchange processes in the reaction kinetics of the antitumor drug cis-diamminedichloroplatinum(II) with its targets.

  1985cited by this paper

• Structural variations in the trans-carboxylate/chlorido axis that impact the mode of action of Pt(ii) complexes

  2025cites this paper
• Supramolecular Coordination Complexes for Synergistic Cancer Therapy.

  2024cites this paper
• Monofunctional dimetallic Ru(η6-arene) complexes inhibit NOTCH1 signaling pathway and synergistically enhance anticancer effect in combination with cisplatin or vitamin C.

  2023cites this paper
• Vitamin B6 based Pt(II) complexes: Biomolecule derived potential cytotoxic agents for thyroid cancer.

  2022cites this paper
• New Findings in the Signaling Pathways of cis and trans Platinum Iodido Complexes’ Interaction with DNA of Cancer Cells

  2019cites this paper
• Mass spectrometry as a powerful tool to study therapeutic metallodrugs speciation mechanisms: Current frontiers and perspectives

  2017cites this paper
• Selective speciation improves efficacy and lowers toxicity of platinum anticancer and vanadium antidiabetic drugs.

  2016cites this paper
• Exploring the mechanisms of metal-based pharmacological agents via an integrated approach.

  2012cites this paper
• Reactivity and biological properties of a series of cytotoxic PtI2(amine)2 complexes, either cis or trans configured.

  2012cites this paper
• Understanding trans platinum complexes as potential antitumor drugs beyond targeting DNA.

  2012cites this paper
• Synthesis, characterization and tumor cell growth inhibition of new trans platinum complexes with phosphane derivatives

  2011cites this paper
• Computational study on the mechanisms of action of the potential anticancer drug trans-isopropylaminedimethylaminedichloroplatinum (trans-IPADMADP) and its cis isomer with DNA purine bases

  2011cites this paper
• Non-classical structures among current platinum complexes with potential as antitumor drugs.

  2011cites this paper
• Recent progress in the application of analytical techniques to anticancer metallodrug proteomics

  2011cites this paper
• Bioanalytical and biophysical techniques for the elucidation of the mode of action of metal-based drugs.

  2011cites this paper
• Non-classical structures among current platinum complexes with potential as antitumor drugs.

  2011cites this paper
• The preparation and characterization of trans-platinum(IV) complexes with unusually high cytotoxicity.

  2011cites this paper
• Interaction of metal complexes with nucleic acids

  2010cites this paper
• Is the reactivity of M(II)-arene complexes of 3-hydroxy-2(1H)-pyridones to biomolecules the anticancer activity determining parameter?

  2010cites this paper
• New reactions of anticancer-platinum complexes and their intriguing behaviour under various experimental conditions.

  2010cites this paper
• Proteins as Possible Targets for Cytotoxic trans‐Platinum(II) Complexes with Aliphatic Amine Ligands: Further Exceptions to the DNA Paradigm

  2010cites this paper
• Cytotoxic Profile and Peculiar Reactivity with Biomolecules of a Novel "Rule-Breaker" Iodidoplatinum(II) Complex.

  2010cites this paper
• A potent trans-diimine platinum anticancer complex photoactivated by visible light.

  2010cites this paper
• The X‐ray Structure of the Adduct between NAMI‐A and Carbonic Anhydrase Provides Insights into the Reactivity of this Metallodrug with Proteins

  2010cites this paper